1164553-54-1

Basic information

• Product Name: 6-cinnamoyl-2H-1,4-benzoxazin-3(4H)-one
• Synonyms: 6-cinnamoyl-2H-1,4-benzoxazin-3(4H)-one
• CAS NO: 1164553-54-1
• Molecular Formula: C17H13NO3
• Molecular Weight: 279.29002
• Mol File: 1164553-54-1.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 6-cinnamoyl-2H-1,4-benzoxazin-3(4H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 6-cinnamoyl-2H-1,4-benzoxazin-3(4H)-one(1164553-54-1)
• EPA Substance Registry System: 6-cinnamoyl-2H-1,4-benzoxazin-3(4H)-one(1164553-54-1)

Safety Data

• Hazardous Substances Data: 1164553-54-1(Hazardous Substances Data)

Upstream product

• 100-52-7 benzaldehyde 
• 26518-71-8 6-acetyl-4H-benzo[1,4]oxazin-3-one 
• 5466-88-6 3,4-dihydro-3-oxo-2H-1,4-benzoxazine 

Downstream Products

• 1347762-30-4 6-(2-methyl-5-phenyl-1H-imidazol-4-yl)-2H-1,4-benzoxazin-3(4H)-one 

Relevant articles and documents

Synthesis of 6-cinnamoyl-2H-benzo[b][1,4]oxazin-3(4H)-ones and their effects on A549 lung cancer cell growth

A series of novel 6-cinnamoyl-2H-benzo[b][1,4]oxazin-3(4H)-one derivatives was synthesized. The structures of compounds were characterized by 1H NMR, IR, and MS. Moreover, representative crystal structure was determined by X-ray diffraction ana

FUSED HETEROCYCLIC COMPOUND AND USE THEREOF

The present invention relates to wherein each symbol is as defined in the specification. The compound has a superior mineral corticoidreceptorantagonistic action and is useful as an agent for the prophylaxis or treatment of hypertension, cardiac failure and the like, a compound having a fused heterocycle, or a prodrug thereof, or a salt thereof; and an agent for the prophylaxis or treatment of hypertension, cardiac failure and the like.